Ϫ . In our view, Heger et al show that modest increases in coupled NOS activity with NO as the main product is not harmful, whereas we show that high levels of uncoupled activity associated with free radical production is associated with cardiac pathology. This view is entirely consistent with the literature.
Of particular importance, several lines of evidence suggest active selection against the generation of mice with high levels of cardiac iNOS activity. First, our attempts to produce nonconditional ␣-MHC-iNOS mice were not successful after screening Ϸ50 founders. Indeed, we would be interested to know how many mice Heger et al screened to generate transgenic founders? Second, in generating the conditional iNOS line, our frequency of genotypepositive founders (1 of 15) was significantly lower than that observed in other lines (1 of 4). Also, in our tTA-dependent iNOS lines, there was no detectable tTA-independent iNOS expression. In comparison, we observe that up to 30% of putatively tTA-dependent transgenes may exhibit some baseline expression (ie, leakiness). The absence of such founders in the iNOS project suggests that leaky expression of iNOS was selected against. Third, in the absence of doxycycline supplementation, there was Ϸ50% reduction in the number of ␣MTA ϩ /iNOS ϩ progeny born. 1 Accordingly, in comparing the phenotypes reported for conditional versus nonconditional ␣-MHCdirected iNOS overexpression, the occurrence of adaptive changes in the Heger mice remains another possible explanation for the differences in phenotypes.
Instead, Wunderlich et al 3 have suggested that nonspecific effects of the tTA or LacZ coexpression could account for the phenotype of our conditional model. This speculation is particularly misleading. First, age-and sex-matched littermate ␣MTA ϩ /iNOS Ϫ controls, which express tTA (but not iNOS) in a cardiac-restricted manner, did not display any evidence of cardiac dysfunction, 1 consistent with many other reports. [5] [6] [7] [8] [9] Second, while doxycycline administration would have suppressed both the expression of iNOS and ␤-gal, the latter is unlikely to have caused our phenotype. ␤-Gal is a widely used reporter gene, and its expression has not previously been reported to generate a cardiac phenotype. 6 Moreover, in our study, line 365iC, which had comparable ␤-gal activity but no iNOS expression (possibly due to transgene truncation/deletion), did not display any incidence of premature mortality. Finally, preliminary experiments using an iNOS-specific inhibitor (1400W), completely rescued the lethal phenotype of ␣MTA ϩ /iNOS ϩ mice (authors' unpublished data, 2003), providing further confirmation that the cardiac manifestations are a result of increased iNOS activity in this model.
In conclusion, while the differences between the two models of enhanced cardiac iNOS remain to be fully explained, it is misleading to dismiss cardiac toxicity as an artifact of the conditional system. Rather, it is more reasonable to suggest that the conditional approach is essential to overcome a lethal phenotype or adaptations that result from high levels of cardiac iNOS overexpression, likely related to uncoupled activity and increased free radical generation. Indeed, the major strength of the tTA-dependent transgenic system is its ability to overcome a well-defined and fundamental weakness of nonconditional transgenic strategies with respect to premature mortality and/or developmental adaptation.
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